BioCentury
ARTICLE | Clinical News

Miravant preclinical data

March 26, 2001 8:00 AM UTC

MRVT said that in hypercholesterolemic rabbits, its MV6401 selectively localized in atherosclerotic plaques. Intravascular light treatment then gave a site-specific reduction in plaque cells. Results ...